Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Sutro Biopharma, Inc. (STRO) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Sutro Biopharma, Inc. (STRO) on November 12, 2026 is 9.57 $, −6.68 % on the day. Over 52 weeks the stock traded between 7.15 $ and 43.85 $; the price now sits 7 % of the way up that range. Over the past year the price changed by +26.67 %. Market capitalization is 87.77 million $, rank 92 among 134 stocks of the same industry with a known capitalization.
Sutro Biopharma, Inc. trades on Nasdaq under the ticker STRO. The company belongs to the Health care sector. The trading history on this page starts on 27 September 2018.
Over the past 52 weeks STRO has traded between 7.15 $ and 43.85 $. As of 12 November 2026 the price stood 8.47% of the way from the 52-week low to the high.
Over one year STRO shares rose 26.67%; over six months they fell 74.09%. Volatility over 90 days is 73.88%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.9, below the sector median of 3.9. Calculated from reports for the period ending 30 June 2026.
Sutro Biopharma, Inc. reported revenue of 46M $ and a net loss of 181M $ over the last four quarters. Net margin is −395.25%. Revenue changed by −56.25% year over year. Earnings per share are −$17.37. Market capitalisation is 88M $.